·HSK 4

Novo Nordisk (Danish pharmaceutical company)
Nuòhé Nuòdé
诺和诺德
with / and
yǔ
与
OpenAI (AI research company)
OpenAI
OpenAI
to reach / to achieve
dáchéng
达成
partnership / cooperation
hézuò
合作
，
to drive / to advance
tuīdòng
推动
artificial intelligence / AI
rénggōng zhìnéng
人工智能
drug development / pharmaceutical R&D
yàowù yánfā
药物研发
。

Denmark / Danish

Dānmài

丹麦

pharmaceutical giant / major drug company

zhìyào jùtóu

制药巨头

Novo Nordisk (Danish pharmaceutical company)

Nuòhé Nuòdé

诺和诺德

to announce / to declare

xuānbù

宣布

with / and

yǔ

与

OpenAI (AI research company)

OpenAI

to establish / to set up

jiànlì

建立

strategic partnership / strategic cooperation

zhànlüè hézuò

战略合作

，

will / shall (future marker)

jiāng

将

artificial intelligence / AI

réngōng zhìnéng

人工智能

technology

jìshù

技术

to introduce / to bring in

yǐnrù

引入

drug / medicine

yàowù

药物

research and development / R&D

yánfā

研发

、

production / manufacturing

shēngchǎn

生产

and / as well as

jí

及

commercial operations / business operations

shāngyè yùnyíng

商业运营

and so on / etc.

děng

等

each / every

gège

各个

link / stage / aspect

huánjié

环节

。

May 18, 2026 at 5:00 AM

Denmark / Danish

Dānmài

丹麦

pharmaceutical giant / major drug company

zhìyào jùtóu

制药巨头

Novo Nordisk (Danish pharmaceutical company)

Nuòhé Nuòdé

诺和诺德

to announce / to declare

xuānbù

宣布

with / and

yǔ

与

OpenAI (AI research company)

OpenAI

to establish / to set up

jiànlì

建立

strategic partnership / strategic cooperation

zhànlüè hézuò

战略合作

relationship / ties

guānxi

关系

。

both parties / the two sides

shuāngfāng

双方

cooperation / partnership

hézuò

合作

to cover / to encompass

hángài

涵盖

drug / medicine

yàowù

药物

research and development / R&D

yánfā

研发

、

clinical trials

línchuáng shìyàn

临床试验

、

production / manufacturing

shēngchǎn

生产

and / as well as

jí

及

supply chain

gōngyìng liàn

供应链

management

guǎnlǐ

管理

and so on / etc.

děng

等

multiple / several

duōgè

多个

domain / field

lǐngyù

领域

。

Novo Nordisk (Danish pharmaceutical company)

Nuòhé Nuòdé

诺和诺德

to hope / to wish

xīwàng

希望

with the help of / by means of

jièzhù

借助

artificial intelligence / AI

réngōng zhìnéng

人工智能

to analyze / analysis

fēnxī

分析

complex / complicated

fùzá

复杂

dataset / data set

shùjùjí

数据集

，

to accelerate / to speed up

jiākuài

加快

new drug / new medicine

xīnyào

新药

from

cóng

从

research

yánjiū

研究

to / until

dào

到

patient / patients

huànzhě

患者

(possessive / modifying particle)

的

cycle / period

zhōuqī

周期

。

this / said (referring to the aforementioned)

gāi

该

cooperation / partnership

hézuò

合作

in / at (a time)

yú

于

April 2026

2026 nián 4 yuè

2026年4月

formally / officially

zhèngshì

正式

to announce / to declare

xuānbù

宣布

，

and / also

bìng

并

to plan / to intend

jìhuà

计划

in / at

zài

在

end of 2026 / late 2026

2026 nián dǐ

2026年底

before / prior to

qián

前

to complete / to finish

wánchéng

完成

comprehensive / full

quánmiàn

全面

to integrate / to consolidate

zhěnghé

整合

。

OpenAI (AI research company)

OpenAI

will also / additionally will

hái jiāng

还将

to assist / to help

xiézhù

协助

Novo Nordisk (Danish pharmaceutical company)

Nuòhé Nuòdé

诺和诺德

in / at

zài

在

global / worldwide

quánqiú

全球

employee / staff

yuángōng

员工

among / in

zhōng

中

to promote / to spread

tuīguǎng

推广

artificial intelligence / AI

réngōng zhìnéng

人工智能

application / use

yìngyòng

应用

ability / capability

nénglì

能力

。

Novo Nordisk (Danish pharmaceutical company)

Nuòhé Nuòdé

诺和诺德

previously / before this

cǐqián

此前

already

yǐ

已

with / and

yǔ

与

Nvidia (semiconductor company)

Yīngwéidá

英伟达

to cooperate / cooperation

hézuò

合作

，

to use / to leverage

lìyòng

利用

supercomputer

chāojí jìsuànjī

超级计算机

used for / applied to

yòng yú

用于

drug / medicine

yàowù

药物

research and development / R&D

yánfā

研发

。

analysts / observers

fēnxī rénshì

分析人士

to think / to believe

rènwéi

认为

，

this cooperation / this partnership

cǐ cì hézuò

此次合作

marks / signifies

biāozhìzhe

标志着

artificial intelligence / AI

réngōng zhìnéng

人工智能

in / at

zài

在

pharmaceutical industry

zhìyào hángyè

制药行业

(possessive / modifying particle)

的

application / use

yìngyòng

应用

to enter / to move into

jìnrù

进入

new phase / new stage

xīn jiēduàn

新阶段

。

New Words

zhiyao

制药

pharmaceutical

hezuo

合作

cooperation

yanfa

研发

R&D

linchuang shiyan

临床试验

clinical trial

shengchan

生产

manufacturing

gongyingxian

供应链

supply chain

rengong zhineng

人工智能

jrakuai

加快

accelerate

yingyong

应用

application

jieduan

阶段

stage

News in English

Science & Technology

Novo Nordisk Partners With OpenAI to Advance AI-Driven Drug Development

Danish pharmaceutical giant Novo Nordisk has announced a strategic partnership with OpenAI to integrate AI across its drug discovery, manufacturing, and commercial operations.

Danish pharmaceutical giant Novo Nordisk announced a strategic partnership with OpenAI to advance AI-driven drug development. The collaboration covers drug development, clinical trials, manufacturing, and supply chain management. Novo Nordisk hopes to leverage AI to analyze complex datasets and accelerate the drug development cycle. The partnership was formally announced in April 2026, with integration expected to complete by end of year. OpenAI will also assist in promoting AI capabilities among Novo Nordisk's global workforce. The company previously collaborated with Nvidia, utilizing supercomputers for drug research. Analysts view this partnership as a milestone for AI applications in the pharmaceutical industry.

New Words

News in English

Novo Nordisk Partners With OpenAI to Advance AI-Driven Drug Development

More in Science & Technology